Abstract:

Purpose: The purpose of this study is to study the relationship between alexity and depression, anxiety, quality of life, disease status and inflammatory signs in Sjögren syndrome (SS) patients. The study included 168 primary SS (pSS) individuals (145 women, 23 men) with an average age of 51.14±9.42 years. To evaluate alchymism, the Toronto alchymism scale, anxiety and depression, the Beck Anxiety and Depression scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale, the World Health Organization’s Life Quality scale. Results: the average alexity of individuals with PSS was 53.83±12.61 points. Anxiety (r:0.514, p:0.00), depression (r:0.522, p:0.00), spiritual (r:0.474, p:0.0) and social (r:0.486, p:0. 04) found a significant ratio of low and medium levels between the subparameters and ESR values (r:0.432, p:0.03). The result: The results of this study show that the increased alexity in individuals with PSS increases the levels of depression, anxiety and inflammatory signs, and the quality of life in mental and social terms decreases. Our results are two-way. Given that alchymitis is mediated by depressive symptoms in pSS, it supports the need for a detailed assessment and a multi-dimensional approach to treatment along with the presence of psychological diseases such as alchymitis, depression and anxiety in pSS.

Keywords: